Antisense reduction of 11β-hydroxysteroid dehydrogenase type 1 enhances energy expenditure and insulin sensitivity independent of food intake in C57BL/6J mice on a Western-type diet.
Antisense reduction of 11β-hydroxysteroid dehydrogenase type 1 enhances energy expenditure and insulin sensitivity independent of food intake in C57BL/6J mice on a Western-type diet.
复制标题
DOI:
10.1016/j.metabol.2011.11.008
复制
发表时间:
2012-06
影响因子:
9.8
通讯作者:
Ginsberg, Henry N.
中科院分区:
文献类型:
--
作者:
Li, Guoping;Hernandez-Ono, Antonio;Crooke, Rosanne M.;Graham, Mark J.;Ginsberg, Henry N.
We recently reported that inhibition of 11beta-hydroxysteroid dehydrogenases 1 (11β-HSD1) by antisense oligonucleotide (ASO) improved hepatic lipid metabolism independent of food intake. In that study, 11β-HSD1 ASO-treated mice lost weight compared to food matched control ASO-treated mice, suggesting treatment-mediated increased energy expenditure. We have now examined the effects of 11β-HSD1 ASO treatment on adipose tissue metabolism, insulin sensitivity, and whole body energy expenditure. We used an ASO to knockdown 11β-HSD1in C57BL/6J mice consuming a Western-type diet (WTD). 11β-HSD1 ASO-treated mice consumed less food, so food-matched control ASO-treated mice were also evaluated. We characterized body composition, gene expression of individual adipose depots, and measures of energy metabolism. We also investigated glucose/insulin tolerance as well as acute insulin signaling in several tissues. Knockdown of 11β-HSD1 protected against WTD-induced obesity by reducing epididymal, mesenteric, and subcutaneous white adipose tissue (WAT) while activating thermogenesis in brown adipose tissue (BAT). The latter was confirmed by demonstrating increased energy expenditure in 11β-HSD1 ASO treated mice. 11β-HSD1 ASO treatment also protected against WTD-induced glucose intolerance and insulin resistance; this protection was associated with smaller cells and fewer macrophages in epididymal WAT as well as enhanced in vivo insulin signaling. Our results indicate that ASO-mediated inhibition of 11β-HSD1 can protect against several WTD-induced metabolic abnormalities. These effects are, at least in part, mediated by increases in the oxidative capacity of BAT.
登录
查看更多内容
DOI:
10.1152/ajpendo.00276.2007
发表时间:
2007-10-01
影响因子:
5.1
作者:
Berthiaume, Magalie;Laplante, Mathieu;Deshaies, Yves
通讯作者:
Deshaies, Yves
影响因子:
29
作者:
Lemke, Ulrike;Krones-Herzig, Anja;Herzig, Stephan
通讯作者:
Herzig, Stephan
影响因子:
6.9
作者:
Lee, Mi-Jeong;Fried, Susan K.;Hermanowski-Vosatka, Anne
通讯作者:
Hermanowski-Vosatka, Anne
影响因子:
4.8
作者:
Morton, NM;Holmes, MC;Seckl, JR
通讯作者:
Seckl, JR
影响因子:
5.8
作者:
Lloyd, D. J.;Helmering, J.;Veniant, M. M.
通讯作者:
Veniant, M. M.